(Q28361123)

English

Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus (English)

0 references

main subject

methicillin-resistant Staphylococcus aureus

0 references

Staphylococcus aureus

1 reference

M Fernandez-Guerrero

1

0 references

M Rouse

series ordinal

2

0 references

N Henry

series ordinal

3

0 references

W Wilson

series ordinal

4

0 references

language of work or name

English

0 references

publication date

May 1988

0 references

published in

Antimicrobial Agents and Chemotherapy

0 references

volume

32

0 references

issue

5

0 references

page(s)

747-51

0 references

cites work

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

29 September 2017

In vitro activity of ciprofloxacin (Bay o 9867)

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

29 September 2017

Experimental endocarditis I. Staphylococcal endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

29 September 2017

Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

29 September 2017

Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

29 September 2017

Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

Staphylococcal bacteremia and endocarditis: state of the art.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

Pharmacokinetics and tissue penetration of ciprofloxacin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

In-vitro studies with ciprofloxacin, a new 4-quinolone compound.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

Antimicrobial Therapy of Experimental Endocarditis Caused by Staphylococcus aureus

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

Single or Combination Therapy of Staphylococcal Endocarditis in Intravenous Drug Abusers

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

27 November 2018

Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

27 November 2018

Vancomycin therapy for methicillin-resistant Staphylococcus aureus

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3164989

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3164989

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of imipenem/cilastatin in endocarditis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3164989

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

0 references

0 references

PubMed publication ID

3164989

0 references

(Q28361123)

Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)